scispace - formally typeset
M

Marc P. van der Schee

Researcher at University of Amsterdam

Publications -  49
Citations -  2389

Marc P. van der Schee is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Asthma & Breath gas analysis. The author has an hindex of 18, co-authored 48 publications receiving 2001 citations. Previous affiliations of Marc P. van der Schee include Leiden University Medical Center & Boston Children's Hospital.

Papers
More filters
Journal ArticleDOI

An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.

TL;DR: VOC-patterns of exhaled breath discriminates patients with lung cancer from COPD patients as well as healthy controls, and the electronic nose may qualify as a non-invasive diagnostic tool for lung cancer in the future.
Journal ArticleDOI

A European respiratory society technical standard : exhaled biomarkers in lung disease

TL;DR: Application of breath biomarker measurement in a standardised manner will provide comparable results, thereby facilitating the potential use of these biomarkers in clinical practice, and highlighting future research priorities in the field.
Journal ArticleDOI

Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.

TL;DR: Molecular profiling of exhaled air can distinguish patients with COPD and asthma and control subjects, and the potential of electronic noses in the differential diagnosis of obstructive airway diseases and in the risk assessment in asymptomatic smokers is demonstrated.
Journal ArticleDOI

Breathomics in Lung Disease

TL;DR: Detailed examination of the nature of volatile biomarkers will improve the understanding of the pathophysiologic origins of these markers and thenature of potential confounders and can enable the development of sensors that exhibit maximum sensitivity and specificity toward specific applications.
Journal ArticleDOI

Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises.

TL;DR: In respiratory medicine, expired volatile organic compounds (VOCs) are associated with inflammatory, oxidative, microbial, and neoplastic processes, which has promoted the development and clinical application of non-invasive metabolomics in exhaled air (breathomics).